Clinical observation on the treatment of cognitive dysfunction in elderly patients after total knee arthroplasty by percutaneous acupoint electrical stimulation of 'ghost point' combined with conventional points

注册号:

Registration number:

ITMCTR2000003038

最近更新日期:

Date of Last Refreshed on:

2020-02-20

注册时间:

Date of Registration:

2020-02-20

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

经皮穴位电刺激“鬼穴”结合常规穴治疗老年患者全膝关节置换术后认知功能障碍的临床观察

Public title:

Clinical observation on the treatment of cognitive dysfunction in elderly patients after total knee arthroplasty by percutaneous acupoint electrical stimulation of 'ghost point' combined with conventional points

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经皮穴位电刺激“鬼穴”结合常规穴治疗老年患者全膝关节置换术后认知功能障碍的临床观察

Scientific title:

Clinical observation on the treatment of cognitive dysfunction in elderly patients after total knee arthroplasty by percutaneous acupoint electrical stimulation of 'ghost point' combined with conventional points

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000030024 ; ChiMCTR2000003038

申请注册联系人:

韦晨浦

研究负责人:

韦晨浦

Applicant:

Chenpu Wei

Study leader:

Chenpu Wei

申请注册联系人电话:

Applicant telephone:

+86 13602450857

研究负责人电话:

Study leader's telephone:

+86 13602450857

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

weichenpu_0@126.com

研究负责人电子邮件:

Study leader's E-mail:

weichenpu_0@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

广州市番禺区大学城内环西路55号

研究负责人通讯地址:

广州市番禺区大学城内环西路55号

Applicant address:

55 Inner Ring Road West, University Town, Panyu District, Guangzhou, Guangdong, China

Study leader's address:

55 Inner Ring Road West, University Town, Panyu District, Guangzhou, Guangdong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广州中医药大学第二附属医院

Applicant's institution:

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

BF2019-142-01

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

广东省中医院伦理委员会

Name of the ethic committee:

Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2019/9/26 0:00:00

伦理委员会联系人:

李晓彦

Contact Name of the ethic committee:

Xiaoyan Li

伦理委员会联系地址:

广州市越秀区大德路111号科研大楼1912室

Contact Address of the ethic committee:

Room 1912, Research Building, 111 Dade Road, Yuexiu District, Guangzhou, Guangdong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 20-81887233-35943

伦理委员会联系人邮箱:

Contact email of the ethic committee:

llbgs@gzucm.edu.cn

研究实施负责(组长)单位:

广州中医药大学第二附属医院

Primary sponsor:

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

研究实施负责(组长)单位地址:

广州市番禺区大学城内环西路55号

Primary sponsor's address:

55 Inner Ring Road West, University Town, Panyu District, Guangzhou, Guangdong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

经费或物资来源:

广东省中医药局

Source(s) of funding:

Guangdong bureau of traditional Chinese medicine

研究疾病:

术后认知功能障碍

研究疾病代码:

Target disease:

POCD

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

探索老年患者全膝关节置换术后经皮穴位电刺激大陵穴,内关穴,印堂穴,劳宫穴,曲池穴的可行性,以及降低术后认知功能障碍的发病率、改善术后脑功能的作用。

Objectives of Study:

To explore the feasibility of transcutaneous electrical stimulation of Daling, Neiguan, Yintang, Laogong and Quchi points in elderly patients after total knee arthroplasty, and the effect of reducing the incidence rate of postoperative cognitive dysfunction and improve postoperative brain function.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1. 年龄65以上80岁以下患者; 2. ASA分级I-III级者; 3. 全膝关节置换术的病人; 4. 可以正常交流。

Inclusion criteria

1. Patients aged 60 to 75 years old; 2. ASA I-III; 3. Patients undergoing total knee arthroplasty; 4. Patients can communicate normally.

排除标准:

1. 有脑部疾病或脑部疾病病史; 2. 通过细微精神状态(MMSE)检查小于24分证明存在认知功能损伤或CAM诊断已有谵妄者; 3. 存在神经和心理疾病的病史包括AD,中风,精神病; 4. 严重的听力或者视力损害。

Exclusion criteria:

1. Got encephalopathy or history of brain diseases; 2. Diagnosis of delirium grade<24 by MMSE or CAM; 3. Got nervous system disease and psychological illness include AD, stroke and mental illness; 4. Serious hearing disorder and visual impairment.

研究实施时间:

Study execute time:

From 2019-12-01

To      2021-11-25

征募观察对象时间:

Recruiting time:

From 2020-02-29

To      2021-11-25

干预措施:

Interventions:

组别:

空白对照组

样本量:

40

Group:

group B

Sample size:

干预措施:

无电刺激

干预措施代码:

Intervention:

NO TEAS

Intervention code:

组别:

经皮穴位电刺激组

样本量:

40

Group:

group A

Sample size:

干预措施:

大陵穴,内关穴,劳宫穴,印堂穴,曲池穴行电刺激

干预措施代码:

Intervention:

Transcutaneous daling point, neiguan point, laogong point, quchi point and yintang point electrical stimulation

Intervention code:

样本总量 Total sample size : 80

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广州中医药大学第二附属医院

单位级别:

三级甲等

Institution/hospital:

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

简易精神状态量表评分

指标类型:

次要指标

Outcome:

MMSE score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

谵妄量表(CAM)评分

指标类型:

主要指标

Outcome:

Delirium scale (CAM-CR) score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它

说明

Fate of sample 

Others

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 65
Min age years
最大 80
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

研究者之一先按病例纳入顺序将患者编号1-80。查随机数字表产生80个两位数的随机数,将随机数从小到大排列后得到序号R,并规定R=1~40者为A组,R=41~80者为B组.

Randomization Procedure (please state who generates the random number sequence and by what method):

One of the researchers number the patients 1-80 according to case inclusion order. Look up the table of Random Numbers to generate 80 random numbers, arrange the random numbers from small to large named number R, specify that R=1-40 is group A, R=41-80 is group B.

盲法:

未说明

Blinding:

Not stated

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2021年通过期刊论文的形式公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Published in the form of periodical papers in 2021

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

本研究通过病例记录表和电子采集和管理系统管理数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

This study recorded clinial data through CRF and EDC.

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above